The Institute of Cancer Research (ICR) in London is teaming up with Healx, a biotech firm known for its expertise in artificial intelligence (AI) and machine learning, to develop potential new therapies for diffuse intrinsic pontine glioma (DIPG), a rare and currently untreatable form of childhood
The digital health landscape in 2024 has been marked by unexpected developments, rapid advancements, and new challenges. Industry executives have reflected on the year's most surprising and impactful occurrences, providing insights into the evolving dynamics of healthcare technology. This article
In recent years, significant advancements have been made in treating pediatric acute lymphocytic leukemia (B-ALL) through combining traditional chemotherapy with innovative drugs like blinatumomab. This blend of treatments, examined in a clinical trial, has shown promising results, particularly in
Imagine a world where a simple leaf extract from an ancient tree could offer a safer and more effective treatment for pain and arthritis, potentially revolutionizing how we manage these chronic conditions. This scenario is not far-fetched, thanks to groundbreaking research on the medicinal
Ichthyosis, a rare genetic skin disorder, presents significant daily challenges for those affected, compelling them to adhere to labor-intensive skincare routines. Unfortunately, this debilitating condition has not captured major pharmaceutical interest, leaving dedicated dermatologists to
The COVID-19 pandemic presented a global challenge, with governments and health institutions striving to contain the virus amid misinformation and rapid transmission. One pivotal approach was the development of various COVID-19 vaccine trials, employing adaptive methods to expedite recruitment
